Wolfgang Seewald

2.9k total citations
84 papers, 2.1k citations indexed

About

Wolfgang Seewald is a scholar working on Small Animals, Pharmacology and Parasitology. According to data from OpenAlex, Wolfgang Seewald has authored 84 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Small Animals, 21 papers in Pharmacology and 19 papers in Parasitology. Recurrent topics in Wolfgang Seewald's work include Inflammatory mediators and NSAID effects (19 papers), Insect and Pesticide Research (13 papers) and Vector-borne infectious diseases (13 papers). Wolfgang Seewald is often cited by papers focused on Inflammatory mediators and NSAID effects (19 papers), Insect and Pesticide Research (13 papers) and Vector-borne infectious diseases (13 papers). Wolfgang Seewald collaborates with scholars based in Switzerland, United States and France. Wolfgang Seewald's co-authors include Jean Steffan, Jonathan N. King, Claude Favrot, Steve Nanchen, Daniela Cavalleri, Martin Murphy, Martin Jung, P. Lees, Jason Drake and Philippe Gruet and has published in prestigious journals such as Experimental Eye Research, Journal of the Royal Statistical Society Series C (Applied Statistics) and Veterinary Parasitology.

In The Last Decade

Wolfgang Seewald

83 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wolfgang Seewald Switzerland 27 695 540 430 353 350 84 2.1k
Aiden Foster United Kingdom 25 284 0.4× 342 0.6× 68 0.2× 108 0.3× 356 1.0× 112 1.7k
Yoshiaki Hikasa Japan 23 633 0.9× 99 0.2× 145 0.3× 144 0.4× 70 0.2× 110 1.7k
Paul Giacomin Australia 33 471 0.7× 140 0.3× 1.5k 3.6× 45 0.1× 258 0.7× 68 4.3k
John R. Grainger United Kingdom 25 383 0.6× 116 0.2× 1.0k 2.4× 30 0.1× 111 0.3× 43 5.2k
W.E. Parish United Kingdom 28 176 0.3× 498 0.9× 45 0.1× 120 0.3× 572 1.6× 85 2.4k
Chiara Noli Italy 21 159 0.2× 432 0.8× 89 0.2× 117 0.3× 268 0.8× 73 1.4k
Matthew R. Hepworth United Kingdom 30 152 0.2× 331 0.6× 497 1.2× 19 0.1× 219 0.6× 57 4.6k
Aharon Friedman Israel 31 226 0.3× 101 0.2× 100 0.2× 32 0.1× 320 0.9× 78 4.2k
Anchalee Tungtrongchitr Thailand 20 98 0.1× 69 0.1× 206 0.5× 70 0.2× 307 0.9× 92 1.4k
W.J. Penhale Australia 31 669 1.0× 70 0.1× 177 0.4× 31 0.1× 74 0.2× 93 3.2k

Countries citing papers authored by Wolfgang Seewald

Since Specialization
Citations

This map shows the geographic impact of Wolfgang Seewald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Seewald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Seewald more than expected).

Fields of papers citing papers by Wolfgang Seewald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang Seewald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Seewald. The network helps show where Wolfgang Seewald may publish in the future.

Co-authorship network of co-authors of Wolfgang Seewald

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang Seewald. A scholar is included among the top collaborators of Wolfgang Seewald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang Seewald. Wolfgang Seewald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cavalleri, Daniela, Martin Murphy, Wolfgang Seewald, & Steve Nanchen. (2018). Laboratory evaluation of the efficacy and speed of kill of lotilaner (Credelio™) against Ctenocephalides felis on cats. Parasites & Vectors. 11(1). 408–408. 10 indexed citations
3.
Murphy, Martin, Daniela Cavalleri, Wolfgang Seewald, Jason Drake, & Steve Nanchen. (2017). Laboratory evaluation of the speed of kill of lotilaner (Credelio™) against Ixodes ricinus ticks on dogs. Parasites & Vectors. 10(1). 541–541. 30 indexed citations
4.
Cavalleri, Daniela, Martin Murphy, Wolfgang Seewald, Jason Drake, & Steve Nanchen. (2017). Assessment of the onset of lotilaner (Credelio™) speed of kill of fleas on dogs. Parasites & Vectors. 10(1). 521–521. 28 indexed citations
5.
Lovis, Léonore, et al.. (2017). Seasonality and circadian variation of microfilaremia in dogs experimentally infected with Dirofilaria immitis. Veterinary Parasitology. 243. 235–241. 6 indexed citations
6.
Cavalleri, Daniela, Martin Murphy, Wolfgang Seewald, Jason Drake, & Steve Nanchen. (2017). A randomised, blinded, controlled field study to assess the efficacy and safety of lotilaner tablets (Credelio™) in controlling fleas in client-owned dogs in European countries. Parasites & Vectors. 10(1). 526–526. 29 indexed citations
7.
Pelligand, Ludovic, Jonathan N. King, Wolfgang Seewald, et al.. (2015). Effect of Cyclooxygenase(COX)-1 and COX-2 inhibition on furosemide-induced renal responses and isoform immunolocalization in the healthy cat kidney. BMC Veterinary Research. 11(1). 296–296. 16 indexed citations
8.
9.
Conboy, Gary, et al.. (2013). Efficacy of Milbemax (milbemycin oxime+praziquantel) in the treatment of dogs experimentally infected with Crenosoma vulpis. Veterinary Parasitology. 198(3-4). 319–324. 12 indexed citations
10.
King, Jonathan N., et al.. (2012). Comparison of injectable robenacoxib versus meloxicam for peri-operative use in cats: Results of a randomised clinical trial. The Veterinary Journal. 193(1). 114–118. 28 indexed citations
11.
12.
Gruet, Philippe, Wolfgang Seewald, & Jonathan N. King. (2011). Evaluation of subcutaneous and oral administration of robenacoxib and meloxicam for the treatment of acute pain and inflammation associated with orthopedic surgery in dogs. American Journal of Veterinary Research. 72(2). 184–193. 40 indexed citations
13.
King, Jonathan N., et al.. (2011). Safety of oral robenacoxib in the cat. Journal of Veterinary Pharmacology and Therapeutics. 35(3). 290–300. 32 indexed citations
14.
Favrot, Claude, Jean Steffan, Wolfgang Seewald, et al.. (2011). Establishment of diagnostic criteria for feline nonflea‐induced hypersensitivity dermatitis. Veterinary Dermatology. 23(1). 45–45. 51 indexed citations
15.
Seewald, Wolfgang, et al.. (2010). In vitroandex vivoinhibition of COX isoforms by robenacoxib in the cat: a comparative study. Journal of Veterinary Pharmacology and Therapeutics. 33(5). 444–452. 27 indexed citations
16.
Spreng, David, et al.. (2009). Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog. Journal of Veterinary Pharmacology and Therapeutics. 33(2). 118–131. 21 indexed citations
17.
Hosking, B.C., Ronald Kaminsky, Heinz Sager, P.F. Rolfe, & Wolfgang Seewald. (2009). A pooled analysis of the efficacy of monepantel, an amino-acetonitrile derivative against gastrointestinal nematodes of sheep. Parasitology Research. 106(2). 529–532. 31 indexed citations
18.
Seewald, Wolfgang, et al.. (2009). Pharmacokinetics of monepantel and its sulfone metabolite, monepantel sulfone, after intravenous and oral administration in sheep. Journal of Veterinary Pharmacology and Therapeutics. 32(4). 359–367. 43 indexed citations
19.
Steffan, Jean, Craig D. Parks, & Wolfgang Seewald. (2005). Clinical trial evaluating the efficacy and safety of cyclosporine in dogs with atopic dermatitis. Journal of the American Veterinary Medical Association. 226(11). 1855–1863. 60 indexed citations
20.
Rest, Joan, et al.. (2004). A prospective study of the clinical findings, treatment and histopathology of 44 cases of pyotraumatic dermatitis. Veterinary Dermatology. 15(6). 369–376. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aiden Foster Breakdown of academic impact, for papers by Yoshiaki Hikasa Breakdown of academic impact, for papers by Paul Giacomin Breakdown of academic impact, for papers by John R. Grainger Breakdown of academic impact, for papers by W.E. Parish Breakdown of academic impact, for papers by Chiara Noli Breakdown of academic impact, for papers by Matthew R. Hepworth Breakdown of academic impact, for papers by Aharon Friedman Breakdown of academic impact, for papers by Anchalee Tungtrongchitr Breakdown of academic impact, for papers by W.J. Penhale
Rankless by CCL
2026